A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery Patients

American Journal of Ophthalmology

Volumn 146, Issue 4, 2008, Pages

  Wittpenn, John R ^a   Silverstein, Steven ^b   Heier, Jeffrey ^c   Kenyon, Kenneth R ^d   Hunkeler, John D ^e   Earl, Melissa ^f  

^a STONY BROOK UNIVERSITY   (United States)

^b Silverstein Eye Centers   (United States)

^c OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^d Eye Health Vision Center   (United States)

^e Hunkeler Eye Institute   (United States)

^f UPMC Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACULAR LS; KETOROLAC TROMETAMOL; PREDNISOLONE ACETATE; UNCLASSIFIED DRUG;

ARTICLE; BURNING SENSATION; CATARACT; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; EYE DISEASE; HUMAN; LACRIMATION; MEASUREMENT; MULTICENTER STUDY; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; PHACOEMULSIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA CYSTOID EDEMA; RISK FACTOR; SIDE EFFECT; SINGLE BLIND PROCEDURE; STINGING SENSATION; THICKNESS; VISUAL ACUITY;

EID: 51649089809     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.04.036     Document Type: Article

References (21)

1. O'Brien T.P. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 21 (2005) 1131-1137 correction: 21:1431-1432
2. Rossetti L., and Autelitano A. Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 11 (2000) 65-72
3. Lobo C.L., Faria P.M., Soares M.A., Bernardes R.C., and Cunha-Vaz J.G. Macular alterations after small-incision cataract surgery. J Cataract Refract Surg 30 (2004) 752-760
4. McColgin A.Z., and Heier J.S. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 11 (2000) 3-6
5. Mentes J., Erakgun T., Afrashi F., and Kerci G. Incidence of cystoid macular edema after uncomplicated phacoemulsification. Ophthalmologica 217 (2003) 408-412
6. Ray S., and D'Amico D.J. Pseudophakic cystoid macular edema. Semin Ophthalmol 17 (2002) 167-180
7. Flach A.J. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96 (1998) 557-634
8. Rossetti L., Chaudhuri J., and Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 105 (1998) 397-405
9. Flach A.J., Stegman R.C., Graham J., and Kruger L.P. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97 (1990) 1253-1258
10. Gulkilik G., Kocabora S., Taskapili M., and Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol 41 (2006) 699-703
11. Schmier J.K., Halpern M.T., Covert D.W., and Matthews G.P. Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 27 (2007) 621-628
12. Flach A.J., Dolan B.J., and Irvine A.R. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 103 (1987) 479-486
13. Flach A.J., Jampol L.M., Weinberg D., et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 112 (1991) 514-519
14. Heier J.S., Topping T.M., Baumann W., Dirks M.S., and Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 107 (2000) 2034-2038
15. Donnenfeld E.D., Perry H.D., Wittpenn J.R., Solomon R., Nattis A., and Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 32 (2006) 1474-1482
16. Snyder R.W., Siekert R.W., Schwiegerling J., Donnenfeld E., and Thompson P. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. J Cataract Refract Surg 26 (2000) 1225-1227
17. Stewart R., Grosserode R., Cheetham J.K., and Rosenthal A. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 21 (1999) 723-732
18. Nicholas S., Riley A., Patel H., Neveldson B., Purdie G., and Wells A.P. Correlations between optical coherence tomography measurement of macular thickness and visual acuity after cataract extraction. Clin Experiment Ophthalmol 34 (2006) 124-129
19. von Jagow B., Ohrloff C., and Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 245 (2007) 1765-1771
20. Perente I., Utine C.A., Ozturker C., et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res 32 (2007) 241-247
21. Degenring R.F., Vey S., Kamppeter B., Budde W.M., Jonas J.B., and Sauder G. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects. Graefes Arch Clin Exp Ophthalmol 245 (2007) 18-23